60d FRN - published

Att B1 - 60-Day Federal Register Notice for NHCS
46488

Federal Register / Vol. 83, No. 178 / Thursday, September 13, 2018 / Notices

182, 140 Stat. 448 (2016), and operates
in accordance with the Federal
Advisory Committee Act (FACA) of
1972. The SACC supports activities
under the Toxic Substances Control Act
(TSCA), 15 U.S.C. 2601 et seq., the
Pollution Prevention Act (PPA), 42
U.S.C. 13101 et seq., and other
applicable statutes. The SACC provides
independent scientific advice and
recommendations to the EPA on the
scientific and technical aspects of risk
assessments, methodologies, and
pollution prevention measures and
approaches for chemicals regulated
under TSCA.
The SACC is comprised of experts in:
Toxicology; environmental risk
assessment; exposure assessment; and
related sciences (e.g., synthetic biology,
pharmacology, biotechnology,
nanotechnology, biochemistry,
biostatistics, PBPK modeling,
computational toxicology,
epidemiology, environmental fate, and
environmental engineering and
sustainability). The SACC currently
consists of 26 members. When needed,
the committee will be assisted in their
reviews by ad hoc reviewers with
specific expertise in the topics under
consideration.
At this time, EPA is seeking
nominations to create a pool of experts
who can be available to the SACC to
assist in reviews conducted by the
Committee. EPA anticipates selecting
experts from this pool, as needed, to
assist the SACC in their review of EPA’s
risk evaluations for the first 10 chemical
substances addressed under the TSCA:
Pigment Violet 29; 1,4-Dioxane,
Asbestos; Cyclic Aliphatic Bromide
Cluster (HBCD); 1-Bromopropane;
Perchloroethylene; Trichloroethylene;
Carbon Tetrachloride; Methylene
Chloride; and n-Methylpyrolidone.
In addition, EPA anticipates selecting
from the pool of experts, as needed, to
appoint SACC members to fulfill short
term needs when a vacancy occurs on
the Committee due to resignation or
reasons other than expiration of a term.

daltland on DSKBBV9HB2PROD with NOTICES

Authority: 15 U.S.C. 2625 et seq.; 5 U.S.C.
Appendix 2 et seq.
Dated: September 4, 2018.
Stanley Barone, Jr.,
Acting Director, Office of Science
Coordination and Policy.
[FR Doc. 2018–19952 Filed 9–12–18; 8:45 am]
BILLING CODE 6560–50–P

VerDate Sep<11>2014

19:20 Sep 12, 2018

Jkt 244001

FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the offices of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than October
1, 2018.
A. Federal Reserve Bank of Dallas
(Robert L. Triplett III, Senior Vice
President) 2200 North Pearl Street,
Dallas, Texas 75201–2272:
1. Davron Santa Fe Properties, Ltd.,
Wolfforth, Texas, RKB Family
Investments LR, LP, DF Family
Investments LR, LP, Ronnie K. Bilbo,
and David L. Foster, all of Lubbock,
Texas; as a group acting in concert, to
acquire voting shares of Peoples
Bancorp, Inc., and indirectly acquire
shares of Peoples Bank, both of
Lubbock, Texas.
Board of Governors of the Federal Reserve
System, September 10, 2018.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2018–19943 Filed 9–12–18; 8:45 am]
BILLING CODE 6210–01–P

Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than October 11,
2018.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. First Busey Corporation,
Champaign, Illinois; to acquire voting
shares of The Banc Ed Corp.,
Edwardsville, Illinois, and thereby
indirectly acquire The Bank of
Edwardsville, Edwardsville, Illinois.
Board of Governors of the Federal Reserve
System, September 10, 2018.
Yao-Chin Chao,
Assistant Secretary of the Board.
[FR Doc. 2018–19942 Filed 9–12–18; 8:45 am]
BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–18–0212; Docket No. CDC–2018–
0084]

FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the

PO 00000

Frm 00013

Fmt 4703

Sfmt 4703

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a

SUMMARY:

E:\FR\FM\13SEN1.SGM

13SEN1

daltland on DSKBBV9HB2PROD with NOTICES

Federal Register / Vol. 83, No. 178 / Thursday, September 13, 2018 / Notices
proposed information collection project
titled National Hospital Care Survey, an
electronic data collection that describes
hospital care utilization in the U.S.
DATES: CDC must receive written
comments on or before November 13,
2018.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
0084 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,

VerDate Sep<11>2014

19:20 Sep 12, 2018

Jkt 244001

including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
The National Hospital Care Survey
(NHCS) (OMB Control Number 0920–
0212; Exp. Date 01/31/2019)—
Revision—National Center for Health
Statistics (NCHS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health
Service (PHS) Act (42 U.S.C. 242k), as
amended, authorizes that the Secretary
of Health and Human Services (DHHS),
acting through NCHS, shall collect
statistics on the extent and nature of
illness and disability of the population
of the United States. This three-year
clearance request for NHCS includes the
collection of all inpatient and
ambulatory Uniform Bill-04 (UB–04)
claims data or electronic health record
(EHR) data as well as the collection of
hospital-level information via a
questionnaire from a sample of 598
hospitals.
The NHCS collects data on patient
care in hospital-based settings to
describe patterns of health care delivery
and utilization in the United States.
NHCS hospital-based settings include
inpatient, emergency (EDs), and
outpatient departments (OPDs). The
survey will provide hospital utilization
statistics for the Nation. In addition, the
NHCS will also be able to monitor
national trends in substance use-related
ED visits including opioid visits.
NHCS consists of a nationally
representative sample of 598 hospitals.
These hospitals are currently being
recruited, and participating hospitals
are submitting all of their inpatient and
ambulatory care patient data in the form
of electronic UB–04 administrative
claims or EHR data. Currently, hospitallevel data are collected through a
questionnaire administered via a web
portal.
This revision seeks approval to
continue voluntary recruitment of
hospitals in the sample for the NHCS;
continue the collection of hospital-level
data through an initial intake

PO 00000

Frm 00014

Fmt 4703

Sfmt 4703

46489

questionnaire and an Annual Hospital
Interview for all sampled hospitals;
continue the collection of electronic
data on inpatient discharges as well as
emergency department (ED) and
outpatient department (OPD) visits
through the collection of EHR data, UB–
04 claims, or a state file; continue
collection of substance-involved ED
visit data through the ED component;
eliminate medical record abstraction of
a sample of ED and OPD visits as part
of the design of the survey; and
postpone frame development for free
standing ambulatory care facilities.
NHCS collects data items at the
hospital, patient, inpatient discharge,
and visit levels. Hospital-level data
items include ownership, number of
staffed beds, hospital service type, and
EHR adoption. Patient-level data items
are collected from electronic data and
include basic demographic information,
personal identifiers, name, address,
social security number (if available),
and medical record number (if
available). Discharge-level data are
collected through the UB–04 claims or
EHR data and include admission and
discharge dates, diagnoses, diagnostic
services, and surgical and non-surgical
procedures. Visit-level data are
collected through EHR data and include
reason for visit, diagnosis, procedures,
medications, substances involved, and
patient disposition.
NHCS data have distinct advantages.
Through the collection of personal
identifiers, NHCS data can be linked to
outside datasets such as the National
Death Index (OMB No. 0920–0215, Exp.
Date 12/31/2019) to calculate postdischarge mortality. Additionally,
NHCS offers unique opportunities to
study opioid-involved health outcomes,
such as repeat hospital encounters for
opioid use and opioid-related mortality
rates.
NHCS users include, but are not
limited to, CDC, Congressional Research
Office, Office of the Assistant Secretary
for Planning and Evaluation (ASPE),
National Institutes of Health, American
Health Care Association, Centers for
Medicare & Medicaid Services (CMS),
SAMHSA, Bureau of the Census, Office
of National Drug Control Policy, state
and local governments, and nonprofit
organizations. Other users of these data
include universities, research
organizations, many in the private
sector, foundations, and a variety of
users in the media.
Data collected through NHCS are
essential for evaluating the health status
of the population, for the planning of
programs and policy to improve health
care delivery systems of the Nation, for
studying morbidity trends, and for

E:\FR\FM\13SEN1.SGM

13SEN1

46490

Federal Register / Vol. 83, No. 178 / Thursday, September 13, 2018 / Notices

research activities in the health field.
Historically, data have been used
extensively in the development and

monitoring of goals for the Year 2000,
2010, and 2020 Healthy People
Objectives.

There is no cost to respondents other
than their time to participate. The total
annualized burden is 7,080 hours.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses
per
respondent

Average
burden per
response
(in hours)

Total
burden
(in hours)

Form name

Hospital Director of Health Information Management (DHIM) or Director of Health Information Technology (DHIT).
Hospital Chief Executive Officer
(CEO)/Chief
Financial
Officer
(CFO).
Hospital DHIM or DHIT .....................

Initial Hospital Intake Questionnaire

150

1

1

150

Recruitment Survey Presentation ....

150

1

1

150

399

12

1

4,788

199

4

1

796

Hospital CEO/CFO ............................

Prepare and transmit UB–04 or
State File for Inpatient and Ambulatory.
Prepare and transmit EHR for Inpatient and Ambulatory.
Annual Hospital Interview ................

598

1

2

1,196

Total ...........................................

...........................................................

........................

........................

........................

7,080

Hospital DHIM or DHIT .....................

Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–19901 Filed 9–12–18; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–0666]

Agency Forms Undergoing Paperwork
Reduction Act Review

daltland on DSKBBV9HB2PROD with NOTICES

Number of
respondents

Type of respondents

In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled National
Healthcare Safety Network to the Office
of Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on May 11,
2018 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:

VerDate Sep<11>2014

19:20 Sep 12, 2018

Jkt 244001

(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street, NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
National Healthcare Safety Network
(0920–0666, Expiration Date 1/31/
2021)—Revision—National Center for

PO 00000

Frm 00015

Fmt 4703

Sfmt 4703

Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
NHSN is a public health surveillance
system that collects, analyzes, reports,
and makes available data for
monitoring, measuring, and responding
to healthcare associated infections
(HAIs), antimicrobial use and resistance,
blood transfusion safety events, and the
extent to which healthcare facilities
adhere to infection prevention practices
and antimicrobial stewardship.
Specifically, resulting data estimates the
magnitude of Healthcare Associated
Infections (HAI), monitor HAI trends,
and facilitate inter-facility and intrafacility comparisons with risk-adjusted
data used for local quality improvement
activities. The data will be used to
detect changes in the epidemiology of
adverse events resulting from new and
current medical therapies and changing
risks. The NHSN currently consists of
six components: Patient Safety,
Healthcare Personnel Safety,
Biovigilance, Long-Term Care Facility
(LTCF), Outpatient Procedure
Component, and Dialysis.
Changes were made to 34 data
collection facility surveys with this
revision ICR. CDC revised three annual
facility surveys for the Patient Safety
component for Hospitals, Long-Term
Acute Care Facilities, and Inpatient
Rehabilitation Facilities. CDC’s
revisions clarify the reporting
requirements for the data collected on
fungal testing, facility locations, and
laboratory testing locations.
Additionally, corresponding response

E:\FR\FM\13SEN1.SGM

13SEN1